|
Name |
Hamuramicin B
|
Molecular Formula | C35H52O7 | |
IUPAC Name* |
(4E,7E,9E,11E,15E,17E,19E,22R)-22-[(2S,3R,4R)-3,7-dihydroxy-4-methyldecan-2-yl]-6,14-dihydroxy-5,8,12-trimethyl-1-oxacyclodocosa-4,7,9,11,15,17,19-heptaene-2,13-dione
|
|
SMILES |
CCCC(CC[C@@H](C)[C@H]([C@H](C)[C@H]1C/C=C/C=C/C=C/C(C(=O)/C(=C/C=C/C(=C/C(/C(=C/CC(=O)O1)/C)O)/C)/C)O)O)O
|
|
InChI |
InChI=1S/C35H52O7/c1-7-14-29(36)21-19-27(5)34(40)28(6)32-18-12-10-8-9-11-17-30(37)35(41)26(4)16-13-15-24(2)23-31(38)25(3)20-22-33(39)42-32/h8-13,15-17,20,23,27-32,34,36-38,40H,7,14,18-19,21-22H2,1-6H3/b9-8+,12-10+,15-13+,17-11+,24-23+,25-20+,26-16+/t27-,28-,29?,30?,31?,32-,34-/m1/s1
|
|
InChIKey |
QLZKMDGIDCWQSD-JXUMEYAQSA-N
|
|
Synonyms |
Hamuramicin B
|
|
CAS | NA | |
PubChem CID | 139589543 | |
ChEMBL ID | NA |
Chemical Classification: |
|
|
---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
---|---|---|---|---|---|---|---|---|
Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference |
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name |
Molecular Weight: | 584.8 | ALogp: | 6.3 |
HBD: | 4 | HBA: | 7 |
Rotatable Bonds: | 8 | Lipinski's rule of five: | Rejected |
Polar Surface Area: | 124.0 | Aromatic Rings: | 1 |
Heavy Atoms: | 42 | QED Weighted: | 0.21 |
Caco-2 Permeability: | -4.695 | MDCK Permeability: | 0.00002050 |
Pgp-inhibitor: | 0.036 | Pgp-substrate: | 0.953 |
Human Intestinal Absorption (HIA): | 0.956 | 20% Bioavailability (F20%): | 0.318 |
30% Bioavailability (F30%): | 0.711 |
Blood-Brain-Barrier Penetration (BBB): | 0.03 | Plasma Protein Binding (PPB): | 98.81% |
Volume Distribution (VD): | 1.11 | Fu: | 3.01% |
CYP1A2-inhibitor: | 0.061 | CYP1A2-substrate: | 0.119 |
CYP2C19-inhibitor: | 0.107 | CYP2C19-substrate: | 0.351 |
CYP2C9-inhibitor: | 0.415 | CYP2C9-substrate: | 0.964 |
CYP2D6-inhibitor: | 0.015 | CYP2D6-substrate: | 0.157 |
CYP3A4-inhibitor: | 0.851 | CYP3A4-substrate: | 0.221 |
Clearance (CL): | 3.732 | Half-life (T1/2): | 0.914 |
hERG Blockers: | 0.241 | Human Hepatotoxicity (H-HT): | 0.622 |
Drug-inuced Liver Injury (DILI): | 0.139 | AMES Toxicity: | 0.121 |
Rat Oral Acute Toxicity: | 0.148 | Maximum Recommended Daily Dose: | 0.971 |
Skin Sensitization: | 0.965 | Carcinogencity: | 0.821 |
Eye Corrosion: | 0.003 | Eye Irritation: | 0.011 |
Respiratory Toxicity: | 0.834 |
Similar NPs | Similar Drugs | ||||||
---|---|---|---|---|---|---|---|
NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
ENC003821 | 0.839 | D05AFC | 0.225 | ||||
ENC004259 | 0.284 | D06LNW | 0.219 | ||||
ENC003155 | 0.283 | D02FEM | 0.214 | ||||
ENC004261 | 0.281 | D02RQU | 0.211 | ||||
ENC004260 | 0.276 | D03LJR | 0.198 | ||||
ENC004257 | 0.273 | D08NLN | 0.195 | ||||
ENC003810 | 0.262 | D0K3QS | 0.195 | ||||
ENC004801 | 0.253 | D0ES1Q | 0.191 | ||||
ENC003672 | 0.250 | D0U5GB | 0.190 | ||||
ENC005129 | 0.245 | D06WTZ | 0.190 |